LFG
NAGE

Larson Financial Group’s Niagen Bioscience NAGE Stock Holding History

Larson Financial Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Sell
517
-86
-14% -$349 ﹤0.01% 3174
2026
Q1 		$2.66K Buy
603
+507
+528% +$2.74K ﹤0.01% 2872
2025
Q4 		$611 Buy
96
+61
+174% +$424 ﹤0.01% 3076
2025
Q3 		$327 Sell
35
-2
-5% -$20 ﹤0.01% 3183
2025
Q2 		$533 Buy
+37
New +$365 ﹤0.01% 2840

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Larson Financial Group's NAGE Position: Q2 2026 in Review

Larson Financial Group reduced its Niagen Bioscience (NAGE) stake by 14% in Q2 2026, selling an estimated $349 and leaving 517 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3174.

Larson Financial Group first reported a position in NAGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.66K in Q1 2026. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Larson Financial Group held 517 shares of Niagen Bioscience worth $1.65K as of Q2 2026.
  • Larson Financial Group sold 86 Niagen Bioscience shares in Q2 2026, an estimated $349.
  • Niagen Bioscience made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3174 holding.
  • Larson Financial Group first reported a position in Niagen Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Niagen Bioscience position peaked at $2.66K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.